Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Share News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.20
Bid: 5.52
Ask: 7.00
Change: 0.08 (1.31%)
Spread: 1.48 (26.812%)
Open: 6.20
High: 6.20
Low: 6.20
Prev. Close: 6.12
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Miners power Footsie gains

Mon, 09th Nov 2009 16:31

Mining stocks were at the vanguard of a strong advance from FTSE 100 as commodity prices were boosted by plans outlined by world leaders over the weekend to continue with stimulus measures.Kazakhmys, Fresnillo, Rio Tinto and Vedanta were some of the best performers in the mining sector.Mining giant Anglo American has added former Sainsbury chairman, Sir Philip Hampton, to the board in a non-executive role. Hampton has been chairman of Royal Bank of Scotland (RBS) since February 2009. After all the waiting and speculation, the formal bid for Cadbury from US group Kraft Foods proved a disappointment.Kraft formally announced a bid for Cadbury on the same terms as the indicative offer announced at the beginning of September. Not surprisingly, the Cadbury board gave the offer short shrift, noting that the terms of 300p cash plus 0.2589 Kraft Foods shares for every Cadbury share actually value each Cadbury share at a lower value now than when the bid terms were first mooted, thanks to the slide in Kraft's share price in the intervening weeks. Cadbury shares initially tumbled from just below 770p to just below 745p on the announcement of the bid terms but later moved back into the blue. The Kraft terms value each Cadbury share at 717p based on Friday's closing share price for Kraft.Prudential went well in a buoyant insurance sector after ING upped its price target for the stock from 392p to 584p.Cash-strapped bank Royal Bank of Scotland is also in demand after week-end analysis of last week's results and government asset protection scheme announcement.Inmarsat was on a high after the satellite operator lifted profits by nearly a third over the past three months. Revenue overall in the three months to September rose by 8.7% to $176.7m (2008: $162.5m). Profit before tax rose by 31% to $70m. Free cash flow rose 6% to $102.9m (2008: $54.0m).Fellow Footsie stock G4S fell, however, after it said things have been steady at the security services firm since August's interims. Operating profit for the first nine months of 2009 was up 25% at actual exchange rates and revenue rose by 23%. At constant exchange rates, profit rose 12% and revenue by 9%.Insurer and reinsurer Beazley has seen strong growth in premiums written this year, even after it pushed through rate increases. Gross premiums written in the first nine months of 2009 rose 45% to £861.9m from £595.4m in the first nine months of last year.Hiscox was in confident mood after boosting premium income by 31.7% in the first nine months of 2009, giving the specialist insurer "good reasons to be optimistic".Sales slumped further at Aer Lingus over the past three months with revenue down by nearly 10% as fares came under heavy pressure both on short-haul and long-haul flights.Oil and gas production levels were both higher in the third quarter at energy company JKX Oil and Gas. Total production in the third quarter of 2009 rose to 13,657 barrels of oil equivalent per day (boepd), up 24% from 10,978 boepd in the same period of 2008.Metal basher IMI has made a thumping gain after saying it expects earnings this year to come in " materially higher" than previously forecast as higher margins have offset a sharp fall in revenues.Shares in online poker giant PartyGaming have come up trumps following the group's purchase of the owner of the World Poker Tour brand. The company has paid £12.3m in cash for WPT Enterprises. Engineering and construction group Costain has been appointed to assist with a roadworks programme in the Midlands arising from the government's fiscal stimulus plan.The share price of respiratory disease drug developer Synairgen more than doubled in early trading on Monday after lab test suggested its inhaled interferon beta product could combat swine flu.FTSE 100 - RisersRoyal Bank of Scotland Group (RBS) 39.40p +6.30%Kazakhmys (KAZ) 1,286.00p +6.02%Prudential (PRU) 608.00p +5.19%Xstrata (XTA) 1,011.00p +5.04%Antofagasta (ANTO) 893.00p +4.63%Vedanta Resources (VED) 2,367.00p +4.60%Inmarsat (ISAT) 621.00p +4.46%Fresnillo (FRES) 875.00p +4.35%Legal & General Group (LGEN) 83.25p +4.32%Rio Tinto (RIO) 3,042.00p +4.29%FTSE 100 - FallersCable & Wireless (CW.) 136.80p -1.58%G4S (GFS) 249.90p -1.15%Next (NXT) 1,967.00p -0.41%WPP Group (WPP) 568.50p +0.09%Severn Trent (SVT) 946.50p +0.11%SEGRO (SGRO) 346.30p +0.14%Capita Group (CPI) 768.50p +0.20%British American Tobacco (BATS) 1,963.00p +0.20%Tesco (TSCO) 418.85p +0.20%British Airways (BAY) 199.30p +0.25%FTSE 250 - RisersIMI (IMI) 529.50p +15.16%Yell Group (YELL) 48.00p +8.72%Punch Taverns (PUB) 93.50p +6.13%Cookson Group (CKSN) 393.60p +5.52%Ferrexpo (FXPO) 168.20p +4.99%Dunelm Group (DNLM) 390.00p +4.64%Bodycote (BOY) 172.50p +4.61%Chloride Group (CHLD) 173.50p +4.58%Talvivaara Mining Company (TALV) 380.30p +4.45%Petropavlovsk (POG) 1,284.00p +4.39%FTSE 250 - FallersForth Ports (FPT) 1,135.00p -4.46%Fidessa (FDSA) 1,217.00p -3.11%Filtrona PLC (FLTR) 174.50p -3.06%Berkeley Group Holdings Units (BKG) 831.00p -2.86%Stobart Group (STOB) 124.50p -2.73%Cranswick (CWK) 680.50p -2.23%Genus (GNS) 634.50p -2.08%Go-Ahead Group (GOG) 1,365.00p -1.87%Avis Europe (AVE) 25.93p -1.78%Morgan Sindall (MGNS) 550.50p -1.70%
More News
6 Jan 2022 14:51

IN BRIEF: Synairgen signs partnership for its Covid-19 treatment in US

IN BRIEF: Synairgen signs partnership for its Covid-19 treatment in US

Read more
11 Nov 2021 18:36

TRADING UPDATES: Avation sells Airbus jet; Mode Global's bitcoin deal

TRADING UPDATES: Avation sells Airbus jet; Mode Global's bitcoin deal

Read more
11 Nov 2021 13:03

Synairgen secures patients for phase III study of Covid treatment, shares jump

(Sharecast News) - Shares in Synairgen rallied on Thursday,after the respiratory drug specialist confirmed it was starting a Phase III study into a potential Covid-19 treatment.

Read more
20 Oct 2021 11:14

IN BRIEF: Synairgen Covid treatment pushed for phase 3 trials by Activ

IN BRIEF: Synairgen Covid treatment pushed for phase 3 trials by Activ

Read more
20 Oct 2021 10:56

AIM WINNERS & LOSERS: Arena soars on takeover; Accrol supply chain hit

AIM WINNERS & LOSERS: Arena soars on takeover; Accrol supply chain hit

Read more
30 Sep 2021 14:42

EARNINGS UPDATES: President Energy slims loss; Jangada turns a profit

EARNINGS UPDATES: President Energy slims loss; Jangada turns a profit

Read more
23 Sep 2021 15:59

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
11 Jun 2021 15:59

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
24 May 2021 12:02

TRADING UPDATES: Digital 9 raises cash; Bluejay and Rio start drilling

TRADING UPDATES: Digital 9 raises cash; Bluejay and Rio start drilling

Read more
24 May 2021 08:33

Synairgen drug proves effective against Covid variants in lab tests

(Sharecast News) - A drug being developed by Synairgen to treat severe lung infections has shown promising laboratory results against emerging variants of Covid-19, the biotech announced on Monday.

Read more
12 May 2021 14:26

TRADING UPDATES: Vertu Motors profit jumps; Mears swings to 2020 loss

TRADING UPDATES: Vertu Motors profit jumps; Mears swings to 2020 loss

Read more
30 Apr 2021 14:15

TRADING UPDATES: Henry Boot gets planning boost; Beximco sales jump

TRADING UPDATES: Henry Boot gets planning boost; Beximco sales jump

Read more
15 Feb 2021 11:57

Synairgen confirms start of dosing in Covid-19 trial

(Sharecast News) - Respiratory drug discovery and development company Synairgen announced on Monday that dosing has started in the inhaled interferon beta formulation 'SNG001' sub-study of the 'ACTIV-2' phase 2 and 3 trial, evaluating patients with mild-to-moderate Covid-19 symptoms not yet requiring hospitalisation.

Read more
15 Feb 2021 10:52

IN BRIEF: Synairgen Begins Dosing Of Covid Patients In SNG001 Sub-Study

IN BRIEF: Synairgen Begins Dosing Of Covid Patients In SNG001 Sub-Study

Read more
25 Jan 2021 19:18

TRADING UPDATES: Intuitive Plots GBP250,000 Investment In Microsaic

TRADING UPDATES: Intuitive Plots GBP250,000 Investment In Microsaic

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.